Skip to main content

Table 2 Single nucleotide polymorphisms used as instrumental variables in the Mendelian randomization analyses of insomnia

From: Impact of insomnia upon inflammatory digestive diseases and biomarkers: a two-sample mendelian randomization research on Europeans

SNP

Chr

A1

A2

SE

Beta

MAF

F-statistics

Nearby gene

P-value

rs2803296

1

C

G

0.001

-0.009

0.544

33

CALML6

7.30E-09

rs12049261

1

C

G

0.002

0.011

0.293

47

RP11-478L17.1

6.80E-12

rs6690017

1

G

T

0.002

-0.010

0.409

46

DAB1

1.10E-11

rs2644128

1

G

C

0.001

0.011

0.548

51

NAV1

1.00E-12

rs4572538

2

T

C

0.002

-0.010

0.364

38

PABPC1P2

7.70E-10

rs56365214

2

A

C

0.002

-0.015

0.156

52

LINC01122

5.60E-13

rs4577309

2

G

A

0.001

-0.009

0.534

33

MFSD6

1.00E-08

rs12470989

2

G

A

0.002

-0.010

0.204

31

MAIP1

2.80E-08

rs113851554

2

T

G

0.003

0.047

0.057

199

MEIS1

2.90E-45

rs56093896

2

A

C

0.002

-0.012

0.214

47

IGKV1OR2-108

7.70E-12

rs2014830

3

T

C

0.002

-0.012

0.304

51

SEMA3F-AS1

8.90E-13

rs705219

3

A

T

0.002

0.013

0.887

33

RP11-384F7.2

1.20E-08

rs9845387

3

A

C

0.004

-0.022

0.040

33

LSAMP

7.10E-09

rs1988337

4

G

A

0.001

0.008

0.552

31

CCSER1

2.10E-08

rs11097861

4

G

A

0.002

0.010

0.716

37

RP11-729M20.1

1.10E-09

rs2604551

4

G

T

0.002

-0.008

0.640

30

RP11-665G4.1

4.70E-08

rs1592757

5

C

G

0.002

0.010

0.356

43

RP11-6N13.1

4.30E-11

rs7711696

5

T

G

0.002

0.011

0.305

48

SMAD5

4.10E-12

rs1430205

5

T

C

0.001

0.009

0.462

40

TMEM161B-AS1

2.10E-10

rs314280

6

G

A

0.001

0.010

0.547

42

LIN28B

7.30E-11

rs6975972

7

G

A

0.002

-0.009

0.579

36

C7orf50

2.00E-09

rs8180817

7

C

G

0.002

-0.010

0.431

44

FOXP2

2.70E-11

rs17151854

8

T

G

0.002

0.013

0.152

39

MSRA

3.80E-10

rs11790060

9

C

T

0.002

-0.010

0.331

43

RP11-165J3.6

5.80E-11

rs224032

10

A

G

0.001

0.008

0.550

32

ALDH7A1P4

1.80E-08

rs17709610

10

G

A

0.002

-0.010

0.298

37

ACTR1A

9.50E-10

rs2297787

10

A

T

0.003

-0.018

0.080

42

CNNM2

9.60E-11

rs72924721

11

T

C

0.003

0.016

0.073

33

CFL1

1.10E-08

rs10838708

11

A

G

0.002

-0.009

0.459

40

PSMC3

2.90E-10

rs68094047

12

T

C

0.002

0.010

0.251

36

MYO1H

1.70E-09

rs931221

12

A

T

0.002

0.011

0.237

37

RP11-788H18.1

1.30E-09

rs324017

12

C

A

0.002

-0.010

0.705

37

NAB2

1.40E-09

rs9570080

13

C

T

0.002

-0.011

0.344

45

RPP40P2

1.60E-11

rs6561715

13

A

T

0.002

-0.012

0.631

57

RP11-384G23.1

4.80E-14

rs1547630

13

A

G

0.002

0.009

0.652

34

SNORD44

5.80E-09

rs4886860

15

C

G

0.002

-0.012

0.767

45

PML

1.80E-11

rs11635495

15

C

T

0.001

0.009

0.512

40

IQCH-AS1

2.80E-10

rs2062113

16

C

T

0.002

-0.010

0.568

41

AC040163.1

1.60E-10

rs9894577

17

A

G

0.002

0.013

0.318

68

HEXIM1

1.30E-16

rs9906181

17

G

A

0.002

-0.009

0.688

31

KCNJ12

2.40E-08

rs11152363

18

A

G

0.002

0.016

0.186

66

TCF4

4.50E-16

rs56330606

19

G

A

0.002

0.009

0.379

37

ZNF585B

1.20E-09

  1. SNP Single-nucleotide polymorphisms, Chr Chromosome, A1 Effect allele, A2 Other allele, SE Standard error, MAF Minor allele frequency